Novavax (NVAX) Earnings Date, Estimates & Call Transcripts

Novavax logo
$8.25 +0.06 (+0.73%)
Closing price 04:00 PM Eastern
Extended Trading
$8.28 +0.04 (+0.42%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novavax Latest Earnings Summary

Upcoming Q4
Earnings Date
May. 8Before Market OpensEstimated
Actual EPS
(Nov. 12)
-$0.76 Beat By $0.07
Consensus EPS
(Nov. 12)
-$0.83

Novavax released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.76, which beat analysts' consensus estimates of -$0.83 by $0.07. Quarterly revenue fell 54.8% year-over-year to $84.51 million, above analyst estimates of $65.80 million. With a trailing EPS of -$2.26,

NVAX Upcoming Earnings

Novavax's next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules.

Get Novavax Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Novavax and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NVAX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NVAX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Novavax Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.63-$0.49-$0.56
Q2 20252$0.44$0.65$0.55
Q3 20252-$0.40-$0.37-$0.39
Q4 20252-$0.57-$0.15-$0.36
FY 20258-$1.16-$0.36-$0.76
Q1 20261-$0.19-$0.19-$0.19
Q2 20261$0.07$0.07$0.07
Q3 20261$0.06$0.06$0.06

Novavax Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/8/2025
(Estimated)
-------
11/12/2024Q3 2024-$0.83-$0.76+$0.07-$0.76$65.80M$84.51M
8/8/2024Q2 2024$1.82$0.99 -$0.83$0.99$458.57M$415.50M
5/10/2024Q1 2024-$1.04-$1.05 -$0.01-$1.05$71.32M$93.90M
2/28/2024Q4 2023-$0.49-$1.44 -$0.95-$1.44$310.96M$291.34M
11/9/2023Q3 2023-$1.82-$1.26+$0.56-$1.26$171.04M$187.00M
8/8/2023Q2 2023-$1.24$0.58+$1.82$0.58$264.16M$424.40M
5/9/2023Q1 2023-$3.38-$3.41 -$0.03-$3.41$94.52M$81.00M
2/28/2023Q4 2022-$0.92-$2.28 -$1.36-$2.28$383.14M$357.40M


This page (NASDAQ:NVAX) was last updated on 2/18/2025 by MarketBeat.com Staff
From Our Partners